Mousseau M - Search Results

1

Monitoring monoclonal antibody delivery in oncology: the example of bevacizumab.

Nugue G, Bidart M, Arlotto M, Mousseau M, Berger F, Pelletier L. Nugue G, et al. Among authors: mousseau m. PLoS One. 2013 Aug 12;8(8):e72021. doi: 10.1371/journal.pone.0072021. eCollection 2013. PLoS One. 2013. PMID: 23951280 Free PMC article.

2

[Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid].

Gauchez AS, Pez E, Boutonnat J, Bourre JC, Pelletier L, Payan R, Mousseau M. Gauchez AS, et al. Among authors: mousseau m. Ann Biol Clin (Paris). 2007 Nov-Dec;65(6):653-8. Ann Biol Clin (Paris). 2007. PMID: 18039611 Free article. French.

3

Kinetics of HER2/neu ECD in 45 patients treated with trastuzumab (Herceptin) between January 2001 and June 2005 at the Grenoble University Hospital.

Gauchez AS, Colonna M, Brand FX, Ravanel N, Pasquier D, Payan R, Mousseau M. Gauchez AS, et al. Among authors: mousseau m. Anticancer Res. 2009 May;29(5):1703-7. Anticancer Res. 2009. PMID: 19443390 Free article.

4

Prospect for anti-HER2 receptor therapy in breast cancer.

Brand FX, Ravanel N, Gauchez AS, Pasquier D, Payan R, Fagret D, Mousseau M. Brand FX, et al. Among authors: mousseau m. Anticancer Res. 2006 Jan-Feb;26(1B):463-70. Anticancer Res. 2006. PMID: 16739306 Free article. Review.

5

Prospect for anti-her2 receptor therapy in breast cancer.

Brand FX, Ravanel N, Gauchez AS, Pasquier D, Payan R, Fagret D, Mousseau M. Brand FX, et al. Among authors: mousseau m. Anticancer Res. 2006 Jan-Feb;26(1B):715-22. Anticancer Res. 2006. PMID: 16739343 Free article. Review.

6

New advances in DPYD genotype and risk of severe toxicity under capecitabine.

Etienne-Grimaldi MC, Boyer JC, Beroud C, Mbatchi L, van Kuilenburg A, Bobin-Dubigeon C, Thomas F, Chatelut E, Merlin JL, Pinguet F, Ferrand C, Meijer J, Evrard A, Llorca L, Romieu G, Follana P, Bachelot T, Chaigneau L, Pivot X, Dieras V, Largillier R, Mousseau M, Goncalves A, Roché H, Bonneterre J, Servent V, Dohollou N, Château Y, Chamorey E, Desvignes JP, Salgado D, Ferrero JM, Milano G. Etienne-Grimaldi MC, et al. Among authors: mousseau m. PLoS One. 2017 May 8;12(5):e0175998. doi: 10.1371/journal.pone.0175998. eCollection 2017. PLoS One. 2017. PMID: 28481884 Free PMC article.

7

[Chemotherapy of brain tumors: biological basis of its limited efficacy].

Mousseau M. Mousseau M. Bull Cancer. 1994 May;81(5):414-24. Bull Cancer. 1994. PMID: 7749219 Review. French.

8

The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein.

Rebischung C, Barnoud R, Stéfani L, Faucheron JL, Mousseau M. Rebischung C, et al. Among authors: mousseau m. Gastric Cancer. 2005;8(4):249-52. doi: 10.1007/s10120-005-0342-7. Gastric Cancer. 2005. PMID: 16328600

9

Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts.

Ramond A, Sartorius E, Mousseau M, Ribuot C, Joyeux-Faure M. Ramond A, et al. Among authors: mousseau m. Exp Biol Med (Maywood). 2008 Jan;233(1):76-83. doi: 10.3181/0706-RM-152. Exp Biol Med (Maywood). 2008. PMID: 18156309

10

Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer.

Pluchart H, Jacquet E, Charlety D, Allenet B, Bedouch P, Mousseau M. Pluchart H, et al. Among authors: mousseau m. Target Oncol. 2016 Oct;11(5):687-691. doi: 10.1007/s11523-016-0429-6. Target Oncol. 2016. PMID: 27041112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page